| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/21/2004 | EP1409550A1 Extracellular messengers |
| 04/21/2004 | EP1409539A1 Method for obtaining a tgf-beta enriched protein fraction in activated form, protein fraction and therapeutic applications |
| 04/21/2004 | EP1409535A2 Human secreted proteins |
| 04/21/2004 | EP1409489A1 6-phenyldihydropyrrolopyrimidinedione derivatives |
| 04/21/2004 | EP1409487A1 Pteridinones as kinase inhibitors |
| 04/21/2004 | EP1409485A1 Novel immunomodulating compounds |
| 04/21/2004 | EP1409483A1 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors |
| 04/21/2004 | EP1409481A1 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 04/21/2004 | EP1409477A1 Piperidine derivatives as nmda receptor antagonists |
| 04/21/2004 | EP1409463A1 N-heterocyclic inhibitors of tnf-alpha expression |
| 04/21/2004 | EP1409455A1 Prostaglandin analogues-as ep4 receptor agonists |
| 04/21/2004 | EP1409453A1 Novel diamines having a casr modulating activity |
| 04/21/2004 | EP1409077A2 Thermotherapy via targeted delivery of nanoscale magnetic particles |
| 04/21/2004 | EP1409023A1 Compositions and preparation methods for bioavailable oral aceaceclofenac dosage forms |
| 04/21/2004 | EP1409016A2 Antibodies to opgl |
| 04/21/2004 | EP1409015A1 Methods for treating or preventing skin disorders using cd2-binding agents |
| 04/21/2004 | EP1409008A1 Use of the disintegrin domain of an adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent |
| 04/21/2004 | EP1409007A2 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 04/21/2004 | EP1409005A1 Modulators of notch signalling for use in immunotherapy |
| 04/21/2004 | EP1409000A4 Use of agaricus blazei murill to prevent or treat skin and other disorders |
| 04/21/2004 | EP1409000A1 Use of agaricus blazei murill to prevent or treat skin and other disorders |
| 04/21/2004 | EP1408999A1 Compositions addressing inflammation and/or degenerative disorders |
| 04/21/2004 | EP1408995A1 Modulating serum amyloid a interaction with tanis and agents useful for same |
| 04/21/2004 | EP1408990A2 Use of hyaluronic acid uronides for the treatment of inflammatory processes |
| 04/21/2004 | EP1408989A2 Method and material for treating immune diseases |
| 04/21/2004 | EP1408987A2 Tetracycline compounds having target therapeutic activities |
| 04/21/2004 | EP1408959A1 Use of galiella lactone |
| 04/21/2004 | EP1408952A1 Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders |
| 04/21/2004 | EP1408951A2 Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers |
| 04/21/2004 | EP1408950A2 Methods of treating cytokine mediated diseases |
| 04/21/2004 | EP1408911A1 Sustained-release therapeutic bioadhesive systems |
| 04/21/2004 | EP1408897A2 Gum resin as a carrier for topical application of pharmacologically active agents |
| 04/21/2004 | EP1408876A1 Zero-order prolonged release coaxial implants |
| 04/21/2004 | EP1296946B1 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof |
| 04/21/2004 | EP1272481B1 4-fluoroalkyl-2h-benzopyrans with anti-estrogenic activity |
| 04/21/2004 | EP1242389B1 Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them |
| 04/21/2004 | EP1228039B1 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 04/21/2004 | EP1154987B1 Phenylalaninol derivatives |
| 04/21/2004 | EP1105370B1 Novel aryl sulphonamides and analogues |
| 04/21/2004 | EP1071701A4 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof |
| 04/21/2004 | EP1049699B1 Pyrazolotriazines as crf antagonists |
| 04/21/2004 | EP0939654B1 Use of no syntase inhibitors with scavengers of oxygen reactive forms for the treatment of ischemia |
| 04/21/2004 | EP0856007B1 Cyclopeptide derivatives |
| 04/21/2004 | EP0683781B1 Novel inhibitors of adenosine monophosphate deaminase |
| 04/21/2004 | CN1491230A Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 04/21/2004 | CN1491227A Triazoloquinazoline and pyrazolotriazolopyrimidine derivatives, medicinal compositions, adenosine A3 receptor affinity agents, ocular tension lowering agents, preparations for preventing and treating |
| 04/21/2004 | CN1491225A Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as active ingredient |
| 04/21/2004 | CN1491222A Piperidinee derivatives as neurokinin/antagonists |
| 04/21/2004 | CN1491197A Tropolone derivative |
| 04/21/2004 | CN1491115A Use of botulinum toxin for treatment of articular pathologies |
| 04/21/2004 | CN1491112A Use of type 4 phosphodiesterase inhibitors in myocardial diseases |
| 04/21/2004 | CN1490335A Method and application of expressions of sTNFR immuno desmolin fusion protein and polypeptide |
| 04/21/2004 | CN1490049A CD26/DPP IV application for medicine in preparing treatment and/or diagnostic disease |
| 04/21/2004 | CN1490034A Medicine composition for treating pain in waist and lower limbs and hyperosteogeny |
| 04/21/2004 | CN1490018A Medicine for treating rheumatic disease |
| 04/21/2004 | CN1490017A Medicines against rheunatoid and rheumatic diseases |
| 04/21/2004 | CN1490007A Quinoline coridalis B drops and preparation thereof |
| 04/21/2004 | CN1489996A Diclofenac sodium pastes and preparation thereof |
| 04/21/2004 | CN1146562C Thtraphydrothiopy 2,3-diazanaphthylaone derivatives as PDE4 inhibitors |
| 04/21/2004 | CN1146552C Azulene hydroxamic acid derivatives as metalloprotein inhibitors |
| 04/21/2004 | CN1146545C Benzoylpyridazines |
| 04/21/2004 | CN1146542C Benzamide derivatives and their use as cytokine inhibitors |
| 04/21/2004 | CN1146541C Beta-alanine derivatives |
| 04/21/2004 | CN1146540C Novel compound with analgesic effect and use thereof |
| 04/21/2004 | CN1146536C Cycloethylene derivatives |
| 04/21/2004 | CN1146441C Composition of containing lympha toxin beta receptor |
| 04/21/2004 | CN1146438C External use medicine bag for stagnation-syndrome |
| 04/21/2004 | CN1146426C Stable aspirin-containing preparations for external use |
| 04/21/2004 | CN1146421C Composition for treating pains and use of medicines in preparation thereof |
| 04/21/2004 | CN1146413C Pharmaceutical composition for injection based on paracetamol |
| 04/21/2004 | CN1146410C Controlled release formulation |
| 04/20/2004 | US6723855 Chlorinating 5-methylisoxazole-4-carboxylic acid by reacting with chlorinating agent to form 5-methylisoxazole-4-carboxylic acid chloride, reacting with 4-trifluoromethylaniline in presence of alkali metal or alkaline earth metal bicarbonate |
| 04/20/2004 | US6723830 Short peptides which selectively modulate the activity of protein kinases |
| 04/20/2004 | US6723754 Controlling pain using transferase inhibitor |
| 04/20/2004 | US6723747 Estrogen receptor modulators useful in treating or inhibiting conditions, disorders, or disease states at least partially mediated by estrogen deficiency or excess, or which may be treated or inhibited through use of estrogenic agent |
| 04/20/2004 | US6723741 Benzimidazoles and benzothiazoles and uses thereof |
| 04/20/2004 | US6723736 For therapy inflammation, inflammatory diseases, immunologic diseases and other diseases mediated by tumor necrosis factor-alpha (tnf-alpha) and/or interleukin 6 or 10 and/or enzyme cyclooxygenase-2 (cox-2) |
| 04/20/2004 | US6723730 Capsaicin receptor ligands |
| 04/20/2004 | US6723721 CRF receptor antagonists and methods relating thereto |
| 04/20/2004 | US6723711 Vascular cell adhesion molecules and fibronectins; asthma, multiple sclerosis, arthritis, inflammatory bowel disease, contact hypersensitivity, cardiac allograft rejection and diabetes treatment |
| 04/20/2004 | US6723525 Methods and compositions for screening modulators of lipid kinases |
| 04/20/2004 | US6723354 Methods and means for preventing or treating inflammation or pruritis |
| 04/20/2004 | US6723350 Powder of one or more antimicrobial metals formed with atomic disorder; coating becomes antimicrobial and anti-inflammatory when wet. |
| 04/20/2004 | US6723343 Pharmaceutical tramadol salts |
| 04/20/2004 | US6723337 Non-aqueous acrylic polymer, superior adhesion and durability instead of water-soluble polymer significantly decreases thickness of patch; non-ionic surfactant and terpene are used as absorption enhancers; dissolution assistant is used |
| 04/20/2004 | CA2296336C Analgesic compositions comprising anti-epileptic compounds and methods of using same |
| 04/15/2004 | WO2004031240A1 Monoclonal antibody anti-c3-2 directed against the third component of complement (c3) and its use in methods to inhibit complement activation |
| 04/15/2004 | WO2004031191A1 Azabicyclic spiroether derivatives as receptor antagonists |
| 04/15/2004 | WO2004031190A1 Azabicyclic amine derivatives as nk-1 receptor antagonists |
| 04/15/2004 | WO2004031188A1 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 04/15/2004 | WO2004031185A1 8-azabicyclo[3.2.1]octane ether derivatives and their use as neurokinin receptor antagonists |
| 04/15/2004 | WO2004031183A1 Novel modification of the compound 4-hydroxy-2-methyl-n-(5-methyl-2-thiazolyl)-2h-1,2-benzothiazine-3-carboxamide-1,1-dioxide in the form of a crystalline acetic acid solvate and use thereof as a medicament |
| 04/15/2004 | WO2004031180A1 Quinazolin-4-one derivatives |
| 04/15/2004 | WO2004031159A1 Substituted 4-(indazol-3-yl)phenols as estrogen receptor (er) ligands and their use in the treatment of inflammatory diseases |
| 04/15/2004 | WO2004031158A1 Indazolecarboxamide derivatives, preparation and use thereof as cdk1, cdk2 and cdk4 inhibitors |
| 04/15/2004 | WO2004031149A1 Substituted gamma-phenyl-delta-lactams and uses related thereto |
| 04/15/2004 | WO2004031105A2 Use of a33 antigens and jam-it |
| 04/15/2004 | WO2004030691A1 Sustained release preparation containing nk4 |
| 04/15/2004 | WO2004030671A2 Use of 4-amino-quinazolines as anti cancer agents |
| 04/15/2004 | WO2004014859A3 Process for preparing quinolin antibiotic intermediates |